查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球電子皮膚貼片市場：按類型、無線連接、應用、最終用戶、地區分類 - 預測至 2029 年
市場調查報告書
商品編碼
1479075

全球電子皮膚貼片市場：按類型、無線連接、應用、最終用戶、地區分類 - 預測至 2029 年

Electronic Skin Patch Market by Type, Wireless Connectivity, Application, End User and Region - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 284 Pages | 訂單完成後即時交付

價格
簡介目錄

電子皮膚貼片市場規模預計將從2024年的150億美元增加至2029年的270億美元，2024年至2029年的複合年成長率為12.5%。

老年人口的增加、軟性電子產品、感測器和無線技術的快速發展，以及傳統醫療保健之外的應用的增加正在推動電子皮膚貼片市場的成長。

調查範圍
調查年份 2020-2029
基準年 2023年
預測期 2024-2029
考慮單位 金額（十億美元）
按細分市場 按類型、按無線連接、按應用、按最終用戶、按區域
目標區域 北美、歐洲、亞太等地區

最近的創新將多個感測器整合在一個貼片中，從而可以同時監測生命徵象和生物標記。電子皮膚貼片在診斷和監測方面的應用廣泛且多樣，涵蓋各種醫療保健環境和疾病狀態。在重症加護病房（例如 ICU）中，這些貼片持續監測心率、血壓、呼吸頻率和體溫等生命徵象。 Dexcom 的連續血糖監測 (CGM) 系統（例如 Dexcom G7）是糖尿病管理的重要工具。這種電子皮膚貼片的應用使糖尿病患者能夠持續監測自己的血糖值，從而無需頻繁刺穿手指。

連網型的電子皮膚貼片利用BLE、Wi-Fi、蜂窩連接、RF技術、乙太網路和近場通訊等無線技術，將內建感測器收集的即時資料傳輸到智慧型手機、智慧型手錶和智慧型手機等設備。至接收主機。這些貼片能夠持續監測生命徵象和健康指標，例如血糖血糖濃度、心率、血壓和體溫。這種即時資料傳輸為醫療保健專業人員提供有關患者健康狀況的最新資訊，有助於對危急情況進行及時干預，並實現遠端患者監控。此外，BLE技術的能源效率使其特別適合電子皮膚貼片等穿戴式設備，確保較長的電池壽命和不間斷的監控。

該報告研究了全球電子皮膚貼片市場，包括按類型、無線連接、應用、最終用戶、地區和參與市場的公司概況分類的趨勢。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

第5章市場概況

  • 介紹
  • 市場動態
  • 影響客戶業務的趨勢/干擾
  • 價格分析
  • 價值鏈分析
  • 生態系分析
  • 投資金籌措場景
  • 技術分析
  • 專利分析
  • 貿易分析
  • 2024-2025年重大會議和活動
  • 案例研究分析
  • 監管狀況
  • 波特五力分析
  • 主要相關人員和採購標準

第6章電子皮膚貼片市場（按類型）

  • 介紹
  • 監控和診斷
  • 治療

第7章無線連接的電子皮膚貼片市場

  • 介紹
  • 聯繫
  • 斷開連接

第8章電子皮膚貼片市場，依應用

  • 介紹
  • 糖尿病管理
  • 心血管監測
  • 一般病患監測
  • 溫度檢測
  • 電刺激
  • 離子電滲
  • 汗液感應
  • 傷口監測和治療
  • 動作感測器
  • 其他

第9章電子皮膚貼片市場，依最終用戶分類

  • 介紹
  • 衛生保健
  • 健身/運動
  • 其他

第10章電子皮膚貼片市場（按地區）

  • 介紹
  • 北美洲
  • 歐洲
  • 亞太地區
  • 其他地區

第11章競爭格局

  • 概述
  • 主要參與企業的策略/秘密，2020-2024
  • 2019-2023年收益分析
  • 2023 年市場佔有率分析
  • 企業價值評估及財務指標
  • 品牌/產品比較
  • 企業評估矩陣：主要參與企業，2023
  • 企業評估矩陣：Start-Ups/小型企業，2023 年
  • 競爭格局及趨勢

第12章 公司簡介

  • 主要參與企業
    • ABBOTT
    • DEXCOM, INC.
    • MEDTRONIC
    • INSULET CORPORATION
    • BOSTON SCIENTIFIC CORPORATION
    • KONINKLIJKE PHILIPS NV
    • BIOLINQ INCORPORATED
    • ZIO BY IRHYTHM TECHNOLOGIES, INC.
    • GENTAG, INC.
    • VITALCONNECT
    • THE SURGICAL COMPANY
    • SENSEONICS LTD.
    • ACTIVE ENVIRONMENTAL SOLUTIONS
  • 其他公司
    • SCOTTCARE
    • VIVALNK, INC.
    • BITTIUM
    • CARDIOMO
    • SEERS TECHNOLOGY
    • SIGKNOW
    • CORTRIUM
    • QARDIO, INC.
    • LIFESIGNALS
    • BLUE SPARK TECHNOLOGIES, INC.
    • EPICORE BIOSYSTEMS
    • HIVOX BIOTEK INC
    • IONTOPATCH
  • CDMO
    • TAPECON, INC.
    • LINXENS
    • QUAD INDUSTRIES
    • BENELI.COM
    • HI-TECH PRODUCTS

第13章附錄

簡介目錄
Product Code: SE 9015

The Electronic Skin Patch market is projected to grow from USD 15.0 billion in 2024 and is projected to reach USD 27.0 billion by 2029; it is expected to grow at a CAGR of 12.5% from 2024 to 2029. Rising geriatric population, Rapid advancements in flexible electronics, sensors and wireless technologies, and Increasing application beyond traditional healthcare to fuel the growth of Electronic Skin Patch market.

Scope of the Report
Years Considered for the Study2020-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD Billion)
SegmentsBy Type, Wireless Connectivity, Application, End User and Region
Regions coveredNorth America, Europe, Asia Pacific, RoW

"Market for Monitoring & Diagnostic to hold the largest share during the forecast period."

Recent innovations have led to integrating multiple sensors within a single patch, enabling the simultaneous monitoring of vital signs and biomarkers. The applications of electronic skin patches for diagnosis and monitoring are vast and diverse, covering various healthcare settings and medical conditions. In critical care settings, such as ICUs these patches continuously monitor vital signs such as heart rate, blood pressure, respiratory rate, and temperature. Dexcom's continuous glucose monitoring (CGM) system, such as the Dexcom G7, is a crucial tool for diabetes management. This application of electronic skin patches enables individuals with diabetes to continuously monitor their blood glucose levels, eliminating the need for frequent finger pricks.

"Market for Connected electronic skin patches holds for largest market share during the forecast period."

Connected electronic skin patches leverage wireless technologies, such as BLE, Wi-Fi, cellular connectivity, RF technology, Ethernet, and near-field communication, to transmit real-time data collected by integrated sensors to receiving devices, such as smartphones, smartwatches, or medical consoles. These patches enable continuous monitoring of vital signs and other health metrics, including glucose levels, heart rate, blood pressure, and temperature. This real-time data transmission provides healthcare professionals with up-to-date information about the patient's health status, facilitating timely intervention for critical situations and enabling remote patient monitoring from a distance. Additionally, the energy efficiency of BLE technology makes it particularly suitable for wearable devices, such as electronic skin patches, ensuring long battery life and uninterrupted monitoring.

"Market for Cardiovascular Monitoring holds for second largest market share during the forecast period."

Electronic skin patches for cardiovascular monitoring provide a promising solution to this pressing need by enabling continuous and non-invasive monitoring of blood pressure, heart rate, and electrocardiogram (ECG) readings. One of the most significant applications of these patches is in electrocardiogram (ECG) monitoring. Patches equipped with ECG sensors, such as AliveCor's KardiaMobile, allow individuals to record their heart rhythm at any time, enabling early detection of potential arrhythmias, such as atrial fibrillation, which can cause serious health consequences. Additionally, these patches can be used to track heart rate variability (HRV), a valuable indicator of overall cardiovascular health and stress levels. Beyond ECG, electronic skin patches can monitor vital signs essential for cardiovascular health assessment. Patches, such as Philips PatchPoint, offer continuous monitoring of blood oxygen levels, heart rate, blood pressure.

"Market for Healthcare segment is projected to hold for largest share during the forecast timeline."

The healthcare industry accounts for major share in electronic skin patch market. The healthcare industry is further segmented into hospitals & clinics, home care/home diagnostics, and diagnostics laboratories. The market is driven with the increasing demand for connected devices with more advanced features and functionalities. The low-cost, disposable, body-worn electronic skin patches play a significant role in monitoring several physiological parameters that can be analyzed remotely to keep track of critical health indicators of patients and check whether they have taken their medication. Wearable patches replace various clinical devices, offering comfort and convenience to patients and healthcare professionals. Remote monitoring and telehealth are emerging concepts in the healthcare industry. Healthcare service providers are adopting electronic skin patches and wireless technologies to improve their relationship with patients. This would reduce the number of hospital visits of patients and bring down the cost of patient care. Sensor patches and related healthcare services continue to improve with better compliance and enhanced security and privacy features.

"North America is expected to have the largest market share during the forecast period."

North America presents promising growth prospects driven by the strong emphasis on self-care and health monitoring, alongside its well-established healthcare infrastructure and commitment to technological progress. The increasing penetration of mobile devices (smartphones, tablets, and PDAs) and the growing popularity of wearables are driving the demand for electronic skin patches. Consumers are aware of new technologies and capabilities of electronic skin patches and are early adopters of new technologies. In addition, consumers seek new and innovative skin patches for monitoring fitness. These factors are major contributors to the growth of the electronic skin patch market in the region.

Extensive primary interviews were conducted with key industry experts in the Electronic Skin Patch market space to determine and verify the market size for various segments and subsegments gathered through secondary research. The break-up of primary participants for the report has been shown below:

The break-up of the profile of primary participants in the Electronic Skin Patch market:

  • By Company Type: Tier 1 - 40%, Tier 2 - 35%, and Tier 3 - 25%
  • By Designation: C Level - 45%, Director Level - 35%, Others-20%
  • By Region: North America - 40%, Europe - 23%, Asia Pacific - 30%, ROW- 7%

The report profiles key players in the Electronic Skin Patch market with their respective market ranking analysis. Prominent players profiled in this report are Abbott (US), Dexcom, Inc. (US), Medtronic (Ireland), Insulet Corporation (US), Boston Scientific Corporation (US), Koninklijke Philips N.V. (Netherlands), Biolinq Incorporated (US), Zio By iRhythm Technologies, Inc. (US), GENTAG, Inc. (US), VitalConnect (US), The Surgical Company (Netherlands), Senseonics Ltd. (US), Active Environmental Solutions (Australia), among others.

Apart from this, ScottCare (US), VivaLNK, Inc. (US), Bittium (Finland), Cardiomo (US), Seers Technology (South Korea), SIGKNOW (Taiwan), Cortrium (Denmark), Qardio, Inc. (US), LifeSignals (US), Blue Spark Technologies, Inc. (US), Epicore Biosystems (US), HIVOX BIOTEK INC. (US), IontoPatch (US)., are among a few emerging companies in the Electronic Skin Patch market.

Research Coverage: This research report categorizes the Electronic Skin Patch market based on Type, Wireless Connectivity, Application, End User, and region. The report describes the major drivers, restraints, challenges, and opportunities pertaining to the Electronic Skin Patch market and forecasts the same till 2029. Apart from these, the report also consists of leadership mapping and analysis of all the companies included in the Electronic Skin Patch ecosystem.

Key Benefits of Buying the Report The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall Electronic Skin Patch Market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

  • Analysis of key drivers (Increasing burden of chronic diseases, Surging demand for remote health monitoring solutions, Rising geriatric population, Rapid advancements in flexible electronics, sensors and wireless technologies) influencing the growth of the Electronic Skin Patch market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the Electronic Skin Patch market.
  • Market Development: Comprehensive information about lucrative markets - the report analysis the Electronic Skin Patch Market across varied regions
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the Electronic Skin Patch Market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Abbott (US), Dexcom, Inc. (US), Medtronic (Ireland), Insulet Corporation (US), Boston Scientific Corporation among others in the Electronic Skin Patch Market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 INCLUSIONS AND EXCLUSIONS
    • 1.3.2 MARKETS COVERED
    • FIGURE 1 ELECTRONIC SKIN PATCH MARKET SEGMENTATION
    • 1.3.3 REGIONAL SCOPE
    • 1.3.4 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 UNITS CONSIDERED
  • 1.6 LIMITATIONS
  • 1.7 STAKEHOLDERS
  • 1.8 IMPACT OF RECESSION
    • FIGURE 2 GDP DECLINE IN MAJOR ECONOMIES, 2021-2023

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 3 ELECTRONIC SKIN PATCH MARKET: RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 List of key secondary sources
      • 2.1.1.2 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 List of primary interview participants
      • 2.1.2.2 Key data from primary sources
      • 2.1.2.3 Key industry insights
      • 2.1.2.4 Breakdown of primaries
    • 2.1.3 SECONDARY AND PRIMARY RESEARCH
  • 2.2 MARKET SIZE ESTIMATION METHODOLOGY
    • FIGURE 4 ELECTRONIC SKIN PATCH MARKET: RESEARCH FLOW
    • 2.2.1 BOTTOM-UP APPROACH
      • 2.2.1.1 Approach to arrive at market size using bottom-up analysis (demand side)
    • FIGURE 5 ELECTRONIC SKIN PATCH MARKET: BOTTOM-UP APPROACH
    • 2.2.2 TOP-DOWN APPROACH
      • 2.2.2.1 Approach to arrive at market size using top-down analysis (supply side)
    • FIGURE 6 ELECTRONIC SKIN PATCH MARKET: TOP-DOWN APPROACH
    • FIGURE 7 ELECTRONIC SKIN PATCH MARKET SIZE ESTIMATION METHODOLOGY (SUPPLY SIDE)
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 8 ELECTRONIC SKIN PATCH MARKET: DATA TRIANGULATION
  • 2.4 RESEARCH ASSUMPTIONS
    • FIGURE 9 ELECTRONIC SKIN PATCH MARKET: RESEARCH ASSUMPTIONS
  • 2.5 RISK ASSESSMENT
    • TABLE 1 ELECTRONIC SKIN PATCH MARKET: RISK ASSESSMENT
  • 2.6 PARAMETERS CONSIDERED TO ANALYZE RECESSION IMPACT ON ELECTRONIC SKIN PATCH MARKET
    • TABLE 2 PARAMETERS CONSIDERED TO ANALYZE RECESSION IMPACT ON ELECTRONIC SKIN PATCH MARKET
  • 2.7 RESEARCH LIMITATIONS
    • FIGURE 10 ELECTRONIC SKIN PATCH MARKET: RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

    • FIGURE 11 MONITORING & DIAGNOSTIC TO ACCOUNT FOR LARGER MARKET SHARE IN 2024
    • FIGURE 12 CONNECTED SEGMENT TO HOLD LARGER SHARE OF ELECTRONIC SKIN PATCH MARKET IN 2029
    • FIGURE 13 HEALTHCARE TO RECORD HIGHEST CAGR IN ELECTRONIC SKIN PATCH MARKET, BY END USER, DURING FORECAST PERIOD
    • FIGURE 14 DIABETES MANAGEMENT APPLICATION TO DOMINATE ELECTRONIC SKIN PATCH MARKET BETWEEN 2024 AND 2029
    • FIGURE 15 ASIA PACIFIC TO EXHIBIT HIGHEST CAGR DURING FORECAST PERIOD

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN ELECTRONIC SKIN PATCH MARKET
    • FIGURE 16 INCREASING PREVALENCE OF DIABETES AND CARDIOVASCULAR DISEASES TO CREATE LUCRATIVE OPPORTUNITIES FOR PLAYERS IN ELECTRONIC SKIN PATCH MARKET
  • 4.2 ELECTRONIC SKIN PATCH MARKET, BY TYPE
    • FIGURE 17 MONITORING & DIAGNOSTIC SEGMENT TO REGISTER HIGHER CAGR FROM 2024 TO 2029
  • 4.3 ELECTRONIC SKIN PATCH MARKET, BY WIRELESS CONNECTIVITY
    • FIGURE 18 CONNECTED SEGMENT TO EXHIBIT HIGHEST CAGR IN ELECTRONIC SKIN PATCH MARKET DURING FORECAST PERIOD
  • 4.4 ELECTRONIC SKIN PATCH MARKET, BY END USER
    • FIGURE 19 HEALTHCARE TO DOMINATE ELECTRONIC SKIN PATCH MARKET, BY END USER, DURING FORECAST PERIOD
  • 4.5 ELECTRONIC SKIN PATCH MARKET, BY APPLICATION
    • FIGURE 20 DIABETES MANAGEMENT TO HOLD LARGEST SHARE OF ELECTRONIC SKIN PATCH MARKET IN 2024
  • 4.6 ELECTRONIC SKIN PATCH MARKET, BY COUNTRY
    • FIGURE 21 ELECTRONIC SKIN PATCH MARKET IN CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 22 ELECTRONIC SKIN PATCH MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing burden of chronic diseases
    • FIGURE 23 NUMBER OF PEOPLE WITH CHRONIC DISEASES IN US
      • 5.2.1.2 Surging demand for remote health monitoring solutions
      • 5.2.1.3 Rising geriatric population
    • FIGURE 24 PROPORTION OF POPULATION AGED OVER 65 YEARS, 2050
      • 5.2.1.4 Rapid advancement in flexible electronics, sensors, and wireless technologies
    • FIGURE 25 IMPACT ANALYSIS: DRIVERS
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Data privacy and security issues
      • 5.2.2.2 High upfront and production costs
    • FIGURE 26 IMPACT ANALYSIS: RESTRAINTS
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Rising emphasis on improving accuracy of health monitoring devices
      • 5.2.3.2 Expanding applications of electronic skin patches beyond traditional healthcare
      • 5.2.3.3 Growing importance of detecting diseases at early stage
    • FIGURE 27 IMPACT ANALYSIS: OPPORTUNITIES
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Data overload and limited processing power
      • 5.2.4.2 Complex regulatory environments
    • FIGURE 28 IMPACT ANALYSIS: CHALLENGES
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • FIGURE 29 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.4 PRICING ANALYSIS
    • 5.4.1 INDICATIVE PRICE TREND OF KEY PLAYERS, BY TYPE
    • FIGURE 30 INDICATIVE PRICE TREND OF KEY PLAYERS, BY TYPE, 2023
    • TABLE 3 INDICATIVE PRICE TREND OF KEY PLAYERS, BY TYPE, 2023
    • 5.4.2 AVERAGE SELLING PRICE TREND, BY REGION
    • FIGURE 31 AVERAGE SELLING PRICE TREND, BY REGION, 2020-2023
  • 5.5 VALUE CHAIN ANALYSIS
    • FIGURE 32 VALUE CHAIN ANALYSIS
  • 5.6 ECOSYSTEM ANALYSIS
    • FIGURE 33 ELECTRONIC SKIN PATCH ECOSYSTEM
    • TABLE 4 ROLE OF COMPANIES IN ELECTRONIC SKIN PATCH ECOSYSTEM
  • 5.7 INVESTMENT AND FUNDING SCENARIO
    • FIGURE 34 INVESTMENT AND FUNDING SCENARIO, 2019-2023
  • 5.8 TECHNOLOGY ANALYSIS
    • 5.8.1 KEY TECHNOLOGIES
      • 5.8.1.1 Miniaturized sensors
      • 5.8.1.2 Biocompatible materials and adhesives
    • 5.8.2 COMPLEMENTARY TECHNOLOGIES
      • 5.8.2.1 Artificial intelligence (AI) and Internet of Things (IoT)
      • 5.8.2.2 Data encryption and security protocols
      • 5.8.2.3 Cloud computing
    • 5.8.3 ADJACENT TECHNOLOGIES
      • 5.8.3.1 Wearable electronics
      • 5.8.3.2 Telemedicine
  • 5.9 PATENT ANALYSIS
    • TABLE 5 ELECTRONIC SKIN PATCH MARKET: LIST OF PATENTS, 2022-2023
    • FIGURE 35 PATENTS APPLIED AND GRANTED, 2014-2023
  • 5.10 TRADE ANALYSIS
    • 5.10.1 IMPORT SCENARIO (HS CODE 901890)
    • FIGURE 36 IMPORT DATA FOR HS CODE 901890-COMPLIANT INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES, BY COUNTRY, 2019-2023 (USD MILLION)
    • 5.10.2 EXPORT SCENARIO (HS CODE 901890)
    • FIGURE 37 EXPORT DATA FOR HS CODE 901890-COMPLIANT INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES, BY COUNTRY, 2019-2023 (USD MILLION)
  • 5.11 KEY CONFERENCES AND EVENTS, 2024-2025
    • TABLE 6 ELECTRONIC SKIN PATCH MARKET: LIST OF CONFERENCES AND EVENTS, 2024-2025
  • 5.12 CASE STUDY ANALYSIS
    • 5.12.1 COVESTRO ENABLES EFFECTIVE MONITORING OF VITAL SIGNS AND HEALTH PARAMETERS USING SENSOR-BASED WEARABLE PATCHES
    • 5.12.2 DUPONT ADDRESSES LONG-TERM MONITORING CHALLENGES WITH NIGHTHAWK SMART PATCHES
    • 5.12.3 MEDHERANT ENSURES ENHANCED DRUG DELIVERY BY LEVERAGING TEPI PATCH TECHNOLOGY
    • 5.12.4 NANOTECH SOLUTIONS ENABLES USERS ACHIEVE HIGH SENSIVITY AND SPECIFICITY USING ADVANCED PATCHES EQUIPPED WITH NANOMATERIAL-BASED SENSORS
    • 5.12.5 TAPE CONVERTERS HOLLAND B.V. ENABLES CONTINUOUS MONITORING OF HYDRATION LEVELS WITH SMART PATCHES
  • 5.13 REGULATORY LANDSCAPE
    • 5.13.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 7 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 8 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 9 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 10 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.13.2 STANDARDS
    • TABLE 11 NORTH AMERICA: SAFETY STANDARDS FOR ELECTRONIC SKIN PATCHES
    • TABLE 12 EUROPE: SAFETY STANDARDS FOR ELECTRONIC SKIN PATCHES
    • TABLE 13 ASIA PACIFIC: SAFETY STANDARDS FOR ELECTRONIC SKIN PATCHES
    • TABLE 14 ROW: SAFETY STANDARDS FOR ELECTRONIC SKIN PATCHES
  • 5.14 PORTER'S FIVE FORCES ANALYSIS
    • FIGURE 38 PORTER'S FIVE FORCES ANALYSIS
    • 5.14.1 THREAT OF NEW ENTRANTS
    • 5.14.2 THREAT OF SUBSTITUTES
    • 5.14.3 BARGAINING POWER OF SUPPLIERS
    • 5.14.4 BARGAINING POWER OF BUYERS
    • 5.14.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 39 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
    • TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS (%)
    • 5.15.2 BUYING CRITERIA
    • FIGURE 40 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
    • TABLE 16 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS

6 ELECTRONIC SKIN PATCH MARKET, BY TYPE

  • 6.1 INTRODUCTION
    • TABLE 17 ELECTRONIC SKIN PATCH MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 18 ELECTRONIC SKIN PATCH MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 19 ELECTRONIC SKIN PATCH MARKET, BY TYPE, 2020-2023 (MILLION UNITS)
    • TABLE 20 ELECTRONIC SKIN PATCH MARKET, BY TYPE, 2024-2029 (MILLION UNITS)
    • FIGURE 41 MONITORING & DIAGNOSTIC TO DOMINATE MARKET, BY TYPE, DURING FORECAST PERIOD
  • 6.2 MONITORING & DIAGNOSTIC
    • 6.2.1 RAPID ADVANCEMENT IN SENSOR TECHNOLOGY TO ACCELERATE SEGMENTAL GROWTH
    • TABLE 21 MONITORING & DIAGNOSTIC: ELECTRONIC SKIN PATCH MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 22 MONITORING & DIAGNOSTIC: ELECTRONIC SKIN PATCH MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 23 MONITORING & DIAGNOSTIC: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 24 MONITORING & DIAGNOSTIC: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 6.3 THERAPEUTIC
    • 6.3.1 REQUIREMENT FOR PRECISE MONITORING OF PATIENTS WITH CARDIOVASCULAR DISEASES TO BOOST SEGMENTAL GROWTH
    • TABLE 25 THERAPEUTIC: ELECTRONIC SKIN PATCH MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 26 THERAPEUTIC: ELECTRONIC SKIN PATCH MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 27 THERAPEUTIC: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 28 THERAPEUTIC: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024-2029 (USD MILLION)

7 ELECTRONIC SKIN PATCH MARKET, BY WIRELESS CONNECTIVITY

  • 7.1 INTRODUCTION
    • TABLE 29 ELECTRONIC SKIN PATCH MARKET, BY WIRELESS CONNECTIVITY, 2020-2023 (USD MILLION)
    • TABLE 30 ELECTRONIC SKIN PATCH MARKET, BY WIRELESS CONNECTIVITY, 2024-2029 (USD MILLION)
    • FIGURE 42 CONNECTED SEGMENT TO ACCOUNT FOR LARGER MARKET SHARE IN 2029
  • 7.2 CONNECTED
    • 7.2.1 RAPID INNOVATION IN AI AND IOT TECHNOLOGIES TO CONTRIBUTE TO SEGMENTAL GROWTH
    • TABLE 31 CONNECTED: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 32 CONNECTED: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 7.3 NON-CONNECTED
    • 7.3.1 ENFORCEMENT OF REGULATIONS TO SAFEGUARD PATIENT HEALTH INFORMATION TO FACILITATE SEGMENTAL GROWTH
    • TABLE 33 NON-CONNECTED: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 34 NON-CONNECTED: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024-2029 (USD MILLION)

8 ELECTRONIC SKIN PATCH MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 35 ELECTRONIC SKIN PATCH MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 36 ELECTRONIC SKIN PATCH MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • FIGURE 43 DIABETES MANAGEMENT APPLICATION TO HOLD LARGEST MARKET SHARE IN 2029
  • 8.2 DIABETES MANAGEMENT
    • 8.2.1 PREFERENCE FOR NON-INVASIVE AND CONTINUOUS GLUCOSE MONITORING SYSTEMS TO DRIVE MARKET
    • TABLE 37 DIABETES MANAGEMENT: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 38 DIABETES MANAGEMENT: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 8.3 CARDIOVASCULAR MONITORING
    • 8.3.1 REQUIREMENT FOR TIMELY INTERVENTION AND TREATMENT OF HEART DISEASES TO FUEL SEGMENTAL GROWTH
    • TABLE 39 CARDIOVASCULAR MONITORING: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 40 CARDIOVASCULAR MONITORING: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 8.4 GENERAL PATIENT MONITORING
    • 8.4.1 USE OF REMOTE MONITORING SOLUTIONS TO DETECT EARLY WARNING SIGNS TO BOOST SEGMENTAL GROWTH
    • TABLE 41 GENERAL PATIENT MONITORING: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 42 GENERAL PATIENT MONITORING: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 8.5 TEMPERATURE SENSING
    • 8.5.1 ADOPTION OF SKIN PATCHES TO PREVENT HYPOTHERMIA AND HYPERTHERMIA IN PRETERM INFANTS TO PROPEL MARKET
    • TABLE 43 TEMPERATURE SENSING: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 44 TEMPERATURE SENSING: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 8.6 ELECTRICAL STIMULATION
    • 8.6.1 USE OF NON-INVASIVE DEVICES IN CHRONIC PAIN AND MUSCULOSKELETAL CONDITION MANAGEMENT TO BOOST SEGMENTAL GROWTH
    • TABLE 45 ELECTRICAL STIMULATION: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 46 ELECTRICAL STIMULATION: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 8.7 IONTOPHORESIS
    • 8.7.1 PREFERENCE FOR ONE-STEP DRUG ADMINISTRATION FOR TREATING INFLAMMATION TO AUGMENT SEGMENTAL GROWTH
    • TABLE 47 IONTOPHORESIS: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 48 IONTOPHORESIS: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 8.8 SWEAT SENSING
    • 8.8.1 USE OF ADVANCED MONITORING SYSTEMS BY ATHLETES AND FITNESS ENTHUSIASTS TO CONTRIBUTE TO SEGMENTAL GROWTH
    • TABLE 49 SWEAT SENSING: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 50 SWEAT SENSING: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 8.9 WOUND MONITORING & TREATMENT
    • 8.9.1 IMPLEMENTATION OF ADVANCED TECHNOLOGIES TO TREAT CHRONIC WOUNDS TO BOOST SEGMENTAL GROWTH
    • TABLE 51 WOUND MONITORING & TREATMENT: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 52 WOUND MONITORING & TREATMENT: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 8.10 MOTION SENSING
    • 8.10.1 IMPLEMENTATION OF REMOTE MONITORING AND TELEHEALTH INITIATIVES TO CONTRIBUTE TO SEGMENTAL GROWTH
    • TABLE 53 MOTION SENSING: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 54 MOTION SENSING: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 8.11 OTHER APPLICATIONS
    • TABLE 55 OTHER APPLICATIONS: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 56 OTHER APPLICATIONS: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024-2029 (USD MILLION)

9 ELECTRONIC SKIN PATCH MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 57 ELECTRONIC SKIN PATCH MARKET, BY END USER, 2020-2023 (USD MILLION)
    • TABLE 58 ELECTRONIC SKIN PATCH MARKET, BY END USER, 2024-2029 (USD MILLION)
    • FIGURE 44 HEALTHCARE SEGMENT TO DOMINATE ELECTRONIC SKIN PATCH MARKET BETWEEN 2024 AND 2029
  • 9.2 HEALTHCARE
    • TABLE 59 ELECTRONIC SKIN PATCH MARKET, BY HEALTHCARE, 2020-2023 (USD MILLION)
    • TABLE 60 ELECTRONIC SKIN PATCH MARKET, BY HEALTHCARE, 2024-2029 (USD MILLION)
    • FIGURE 45 HOME CARE SEGMENT TO EXHIBIT HIGHEST CAGR IN ELECTRONIC SKIN PATCH MARKET, BY HEALTHCARE, DURING FORECAST PERIOD
    • TABLE 61 HEALTHCARE: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 62 HEALTHCARE: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024-2029 (USD MILLION)
    • 9.2.1 HOSPITALS & CLINICS
      • 9.2.1.1 Growing emphasis on preventive healthcare for patients with cardiovascular diseases to drive market
    • TABLE 63 HOSPITALS & CLINICS: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 64 HOSPITALS & CLINICS: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024-2029 (USD MILLION)
    • 9.2.2 HOME CARE
      • 9.2.2.1 Increasing need for remote monitoring of geriatric population susceptible to chronic diseases to foster segmental growth
    • TABLE 65 HOME CARE: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 66 HOME CARE: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024-2029 (USD MILLION)
    • 9.2.3 DIAGNOSTIC LABORATORIES
      • 9.2.3.1 Rising burden of cancer to contribute to segmental growth
    • TABLE 67 DIAGNOSTIC LABORATORIES: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 68 DIAGNOSTIC LABORATORIES: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 9.3 FITNESS & SPORTS
    • 9.3.1 INCREASING AWARENESS OF MONITORING PHYSIOLOGICAL PARAMETERS AMONG ATHLETES TO PROPEL MARKET
    • TABLE 69 FITNESS & SPORTS: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 70 FITNESS & SPORTS: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 9.4 OTHER END USERS
    • TABLE 71 OTHER END USERS: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 72 OTHER END USERS: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024-2029 (USD MILLION)

10 ELECTRONIC SKIN PATCH MARKET, BY REGION

  • 10.1 INTRODUCTION
    • FIGURE 46 NORTH AMERICA TO HOLD LARGEST MARKET SHARE IN 2029
    • TABLE 73 ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 74 ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 10.2 NORTH AMERICA
    • 10.2.1 RECESSION IMPACT ON ELECTRONIC SKIN PATCH MARKET IN NORTH AMERICA
    • FIGURE 47 NORTH AMERICA: ELECTRONIC SKIN PATCH MARKET SNAPSHOT
    • FIGURE 48 US TO HOLD LARGEST SHARE OF NORTH AMERICAN ELECTRONIC SKIN PATCH MARKET IN 2029
    • TABLE 75 NORTH AMERICA: ELECTRONIC SKIN PATCH MARKET, BY COUNTRY, 2020-2023 (USD MILLION)
    • TABLE 76 NORTH AMERICA: ELECTRONIC SKIN PATCH MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
    • TABLE 77 NORTH AMERICA: ELECTRONIC SKIN PATCH MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 78 NORTH AMERICA: ELECTRONIC SKIN PATCH MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 79 NORTH AMERICA: ELECTRONIC SKIN PATCH MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 80 NORTH AMERICA: ELECTRONIC SKIN PATCH MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 81 NORTH AMERICA: ELECTRONIC SKIN PATCH MARKET, BY WIRELESS CONNECTIVITY, 2020-2023 (USD MILLION)
    • TABLE 82 NORTH AMERICA: ELECTRONIC SKIN PATCH MARKET, BY WIRELESS CONNECTIVITY, 2024-2029 (USD MILLION)
    • TABLE 83 NORTH AMERICA: ELECTRONIC SKIN PATCH MARKET, BY END USER, 2020-2023 (USD MILLION)
    • TABLE 84 NORTH AMERICA: ELECTRONIC SKIN PATCH MARKET, BY END USER, 2024-2029 (USD MILLION)
    • 10.2.2 US
      • 10.2.2.1 Increasing healthcare expenditure and elderly population to contribute to market growth
    • 10.2.3 CANADA
      • 10.2.3.1 Surging demand for self-administered drug treatments from chronic disease patients to boost market growth
    • 10.2.4 MEXICO
      • 10.2.4.1 Rising premature deaths caused by chronic diseases to fuel market growth
  • 10.3 EUROPE
    • 10.3.1 RECESSION IMPACT ON ELECTRONIC SKIN PATCH MARKET IN EUROPE
    • FIGURE 49 EUROPE: ELECTRONIC SKIN PATCH MARKET SNAPSHOT
    • FIGURE 50 UK TO RECORD HIGHEST CAGR IN EUROPEAN ELECTRONIC SKIN PATCH MARKET DURING FORECAST PERIOD
    • TABLE 85 EUROPE: ELECTRONIC SKIN PATCH MARKET, BY COUNTRY, 2020-2023 (USD MILLION)
    • TABLE 86 EUROPE: ELECTRONIC SKIN PATCH MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
    • TABLE 87 EUROPE: ELECTRONIC SKIN PATCH MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 88 EUROPE: ELECTRONIC SKIN PATCH MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 89 EUROPE: ELECTRONIC SKIN PATCH MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 90 EUROPE: ELECTRONIC SKIN PATCH MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 91 EUROPE: ELECTRONIC SKIN PATCH MARKET, BY WIRELESS CONNECTIVITY, 2020-2023 (USD MILLION)
    • TABLE 92 EUROPE: ELECTRONIC SKIN PATCH MARKET, BY WIRELESS CONNECTIVITY, 2024-2029 (USD MILLION)
    • TABLE 93 EUROPE: ELECTRONIC SKIN PATCH MARKET, BY END USER, 2020-2023 (USD MILLION)
    • TABLE 94 EUROPE: ELECTRONIC SKIN PATCH MARKET, BY END USER, 2024-2029 (USD MILLION)
    • 10.3.2 GERMANY
      • 10.3.2.1 Increasing investment in advanced healthcare systems to augment market growth
    • 10.3.3 UK
      • 10.3.3.1 Growing burden of chronic diseases to contribute to market growth
    • 10.3.4 FRANCE
      • 10.3.4.1 Rising geriatric population requiring long-term care to drive market
    • 10.3.5 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 RECESSION IMPACT ON ELECTRONIC SKIN PATCH MARKET IN ASIA PACIFIC
    • FIGURE 51 ASIA PACIFIC: ELECTRONIC SKIN PATCH MARKET SNAPSHOT
    • FIGURE 52 CHINA TO EXHIBIT HIGHEST CAGR IN MARKET FROM 2024 TO 2029
    • TABLE 95 ASIA PACIFIC: ELECTRONIC SKIN PATCH MARKET, BY COUNTRY, 2020-2023 (USD MILLION)
    • TABLE 96 ASIA PACIFIC: ELECTRONIC SKIN PATCH MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
    • TABLE 97 ASIA PACIFIC: ELECTRONIC SKIN PATCH MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 98 ASIA PACIFIC: ELECTRONIC SKIN PATCH MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 99 ASIA PACIFIC: ELECTRONIC SKIN PATCH MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 100 ASIA PACIFIC: ELECTRONIC SKIN PATCH MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 101 ASIA PACIFIC: ELECTRONIC SKIN PATCH MARKET, BY WIRELESS CONNECTIVITY, 2020-2023 (USD MILLION)
    • TABLE 102 ASIA PACIFIC: ELECTRONIC SKIN PATCH MARKET, BY WIRELESS CONNECTIVITY, 2024-2029 (USD MILLION)
    • TABLE 103 ASIA PACIFIC: ELECTRONIC SKIN PATCH MARKET, BY END USER, 2020-2023 (USD MILLION)
    • TABLE 104 ASIA PACIFIC: ELECTRONIC SKIN PATCH MARKET, BY END USER, 2024-2029 (USD MILLION)
    • 10.4.2 CHINA
      • 10.4.2.1 Increasing diabetic population and chronic disease prevalence to drive market
    • 10.4.3 JAPAN
      • 10.4.3.1 Rising government initiative to modernize healthcare facilities to fuel market growth
    • 10.4.4 SOUTH KOREA
      • 10.4.4.1 Growing medical tourism due to improved healthcare infrastructure to expedite market growth
    • 10.4.5 REST OF ASIA PACIFIC
  • 10.5 ROW
    • 10.5.1 RECESSION IMPACT ON ELECTRONIC SKIN PATCH MARKET IN ROW
    • FIGURE 53 ROW: ELECTRONIC SKIN PATCH MARKET SNAPSHOT
    • FIGURE 54 SOUTH AMERICA TO EXHIBIT HIGHEST CAGR IN ELECTRONIC SKIN PATCH MARKET DURING FORECAST PERIOD
    • TABLE 105 ROW: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 106 ROW: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024-2029 (USD MILLION)
    • TABLE 107 ROW: ELECTRONIC SKIN PATCH MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 108 ROW: ELECTRONIC SKIN PATCH MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 109 ROW: ELECTRONIC SKIN PATCH MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 110 ROW: ELECTRONIC SKIN PATCH MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 111 ROW: ELECTRONIC SKIN PATCH MARKET, BY WIRELESS CONNECTIVITY, 2020-2023 (USD MILLION)
    • TABLE 112 ROW: ELECTRONIC SKIN PATCH MARKET, BY WIRELESS CONNECTIVITY, 2024-2029 (USD MILLION)
    • TABLE 113 ROW: ELECTRONIC SKIN PATCH MARKET, BY END USER, 2020-2023 (USD MILLION)
    • TABLE 114 ROW: ELECTRONIC SKIN PATCH MARKET, BY END USER, 2024-2029 (USD MILLION)
    • 10.5.2 SOUTH AMERICA
      • 10.5.2.1 Rising disposable income and healthcare spending to contribute to market growth
    • 10.5.3 MIDDLE EAST
      • 10.5.3.1 Growing emphasis on improving healthcare infrastructure to cater to patients with chronic diseases to support market growth
      • 10.5.3.2 GCC countries
      • 10.5.3.3 Rest of Middle East
    • TABLE 115 MIDDLE EAST: ELECTRONIC SKIN PATCH MARKET, BY COUNTRY, 2020-2023 (USD MILLION)
    • TABLE 116 MIDDLE EAST: ELECTRONIC SKIN PATCH MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
    • 10.5.4 AFRICA
      • 10.5.4.1 Increasing implementation of strategies to tackle non-communicable diseases to drive market

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020-2024
    • TABLE 117 ELECTRONIC SKIN PATCH MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, 2020-2024
  • 11.3 REVENUE ANALYSIS, 2019-2023
    • FIGURE 55 ELECTRONIC SKIN PATCH MARKET: REVENUE ANALYSIS OF TOP FIVE PLAYERS, 2019-2023
  • 11.4 MARKET SHARE ANALYSIS, 2023
    • TABLE 118 ELECTRONIC SKIN PATCH MARKET: DEGREE OF COMPETITION, 2023
    • FIGURE 56 ELECTRONIC SKIN PATCH MARKET SHARE ANALYSIS, 2023
  • 11.5 COMPANY VALUATION AND FINANCIAL METRICS
    • FIGURE 57 COMPANY VALUATION
    • FIGURE 58 FINANCIAL METRICS
  • 11.6 BRAND/PRODUCT COMPARISON
    • FIGURE 59 BRAND/PRODUCT COMPARISON
  • 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 11.7.1 STARS
    • 11.7.2 EMERGING LEADERS
    • 11.7.3 PERVASIVE PLAYERS
    • 11.7.4 PARTICIPANTS
    • FIGURE 60 ELECTRONIC SKIN PATCH MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
    • 11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 11.7.5.1 Overall footprint
    • FIGURE 61 ELECTRONIC SKIN PATCH MARKET: OVERALL FOOTPRINT
      • 11.7.5.2 Type footprint
    • TABLE 119 ELECTRONIC SKIN PATCH MARKET: TYPE FOOTPRINT
      • 11.7.5.3 Application footprint
    • TABLE 120 ELECTRONIC SKIN PATCH MARKET: APPLICATION FOOTPRINT
      • 11.7.5.4 End user footprint
    • TABLE 121 ELECTRONIC SKIN PATCH MARKET: END USER FOOTPRINT
      • 11.7.5.5 Wireless connectivity footprint
    • TABLE 122 ELECTRONIC SKIN PATCH MARKET: WIRELESS CONNECTIVITY FOOTPRINT
      • 11.7.5.6 Region footprint
    • TABLE 123 ELECTRONIC SKIN PATCH MARKET: REGION FOOTPRINT
  • 11.8 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
    • 11.8.1 PROGRESSIVE COMPANIES
    • 11.8.2 RESPONSIVE COMPANIES
    • 11.8.3 DYNAMIC COMPANIES
    • 11.8.4 STARTING BLOCKS
    • FIGURE 62 ELECTRONIC SKIN PATCH MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023
    • 11.8.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023
      • 11.8.5.1 Detailed list of key start-ups/SMEs
    • TABLE 124 ELECTRONIC SKIN PATCH MARKET: LIST OF KEY START-UPS/SMES
      • 11.8.5.2 Competitive benchmarking of key start-ups/SMEs
    • TABLE 125 ELECTRONIC SKIN PATCH MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES
  • 11.9 COMPETITIVE SCENARIO AND TRENDS
    • 11.9.1 PRODUCT LAUNCHES
    • TABLE 126 ELECTRONIC SKIN PATCH MARKET: PRODUCT LAUNCHES, JANUARY 2020-APRIL 2024
    • 11.9.2 DEALS
    • TABLE 127 ELECTRONIC SKIN PATCH MARKET: DEALS, JANUARY 2020-APRIL 2024

12 COMPANY PROFILES

  • (Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)**
  • 12.1 KEY PLAYERS
    • 12.1.1 ABBOTT
    • TABLE 128 ABBOTT: COMPANY OVERVIEW
    • FIGURE 63 ABBOTT: COMPANY SNAPSHOT
    • TABLE 129 ABBOTT: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 130 ABBOTT: PRODUCT LAUNCHES
    • TABLE 131 ABBOTT: DEALS
    • 12.1.2 DEXCOM, INC.
    • TABLE 132 DEXCOM, INC.: COMPANY OVERVIEW
    • FIGURE 64 DEXCOM, INC.: COMPANY SNAPSHOT
    • TABLE 133 DEXCOM, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 134 DEXCOM, INC.: PRODUCT LAUNCHES
    • TABLE 135 DEXCOM, INC.: DEALS
    • TABLE 136 DEXCOM, INC.: OTHERS
    • 12.1.3 MEDTRONIC
    • TABLE 137 MEDTRONIC: COMPANY OVERVIEW
    • FIGURE 65 MEDTRONIC: COMPANY SNAPSHOT
    • TABLE 138 MEDTRONIC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 139 MEDTRONIC: PRODUCT LAUNCHES
    • TABLE 140 MEDTRONIC: DEALS
    • TABLE 141 MEDTRONIC: OTHERS
    • 12.1.4 INSULET CORPORATION
    • TABLE 142 INSULET CORPORATION: COMPANY OVERVIEW
    • FIGURE 66 INSULET CORPORATION: COMPANY SNAPSHOT
    • TABLE 143 INSULET CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 144 INSULET CORPORATION: PRODUCT LAUNCHES
    • TABLE 145 INSULET CORPORATION: DEALS
    • 12.1.5 BOSTON SCIENTIFIC CORPORATION
    • TABLE 146 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
    • FIGURE 67 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
    • TABLE 147 BOSTON SCIENTIFIC CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 148 BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES
    • TABLE 149 BOSTON SCIENTIFIC CORPORATION: DEALS
    • TABLE 150 BOSTON SCIENTIFIC CORPORATION: OTHERS
    • 12.1.6 KONINKLIJKE PHILIPS N.V.
    • TABLE 151 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
    • FIGURE 68 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
    • TABLE 152 KONINKLIJKE PHILIPS N.V.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 153 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES
    • TABLE 154 KONINKLIJKE PHILIPS N.V.: DEALS
    • TABLE 155 KONINKLIJKE PHILIPS N.V.: OTHERS
    • 12.1.7 BIOLINQ INCORPORATED
    • TABLE 156 BIOLINQ INCORPORATED: COMPANY OVERVIEW
    • TABLE 157 BIOLINQ INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 158 BIOLINQ INCORPORATED: DEALS
    • 12.1.8 ZIO BY IRHYTHM TECHNOLOGIES, INC.
    • TABLE 159 ZIO BY IRHYTHM TECHNOLOGIES, INC.: COMPANY OVERVIEW
    • FIGURE 69 ZIO BY IRHYTHM TECHNOLOGIES, INC.: COMPANY SNAPSHOT
    • TABLE 160 ZIO BY IRHYTHM TECHNOLOGIES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 161 ZIO BY IRHYTHM TECHNOLOGIES, INC.: PRODUCT LAUNCHES
    • TABLE 162 ZIO BY IRHYTHM TECHNOLOGIES, INC.: DEALS
    • 12.1.9 GENTAG, INC.
    • TABLE 163 GENTAG, INC.: COMPANY OVERVIEW
    • TABLE 164 GENTAG, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • 12.1.10 VITALCONNECT
    • TABLE 165 VITALCONNECT: COMPANY OVERVIEW
    • TABLE 166 VITALCONNECT: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 167 VITALCONNECT: PRODUCT LAUNCHES
    • TABLE 168 VITALCONNECT: DEALS
    • 12.1.11 THE SURGICAL COMPANY
    • TABLE 169 THE SURGICAL COMPANY: COMPANY OVERVIEW
    • TABLE 170 THE SURGICAL COMPANY: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 171 THE SURGICAL COMPANY: DEALS
    • TABLE 172 THE SURGICAL COMPANY: EXPANSIONS
    • 12.1.12 SENSEONICS LTD.
    • TABLE 173 SENSEONICS LTD.: COMPANY OVERVIEW
    • FIGURE 70 SENSEONICS LTD.: COMPANY SNAPSHOT
    • TABLE 174 SENSEONICS LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 175 SENSEONICS LTD.: DEALS
    • 12.1.13 ACTIVE ENVIRONMENTAL SOLUTIONS
    • TABLE 176 ACTIVE ENVIRONMENTAL SOLUTIONS: COMPANY OVERVIEW
    • TABLE 177 ACTIVE ENVIRONMENTAL SOLUTIONS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • 12.2 OTHER PLAYERS
    • 12.2.1 SCOTTCARE
    • 12.2.2 VIVALNK, INC.
    • 12.2.3 BITTIUM
    • 12.2.4 CARDIOMO
    • 12.2.5 SEERS TECHNOLOGY
    • 12.2.6 SIGKNOW
    • 12.2.7 CORTRIUM
    • 12.2.8 QARDIO, INC.
    • 12.2.9 LIFESIGNALS
    • 12.2.10 BLUE SPARK TECHNOLOGIES, INC.
    • 12.2.11 EPICORE BIOSYSTEMS
    • 12.2.12 HIVOX BIOTEK INC
    • 12.2.13 IONTOPATCH
  • 12.3 CDMO PLAYERS
    • 12.3.1 TAPECON, INC.
    • 12.3.2 LINXENS
    • 12.3.3 QUAD INDUSTRIES
    • 12.3.4 BENELI.COM
    • 12.3.5 HI-TECH PRODUCTS
  • *Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)** might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 INSIGHTS FROM INDUSTRY EXPERTS
  • 13.2 DISCUSSION GUIDE
  • 13.3 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4 CUSTOMIZATION OPTIONS
  • 13.5 RELATED REPORTS
  • 13.6 AUTHOR DETAILS